Table 6 JI predicted drug-disease associations (top 10 in ranking list), and the corresponding evidence
From: Drug repositioning based on individual bi-random walks on a heterogeneous network
Drug | Disease | Evidence (PMID) | Rank |
|---|---|---|---|
Alprostadil | Tetralogy of Fallot | 3543871 | 1 |
Alprostadil | Tricuspid Atresia | without evidence | 2 |
Alprostadil | Hypoplastic Left Heart Syndrome | without evidence | 3 |
Cefepime | Escherichia coli Infections | 26815433 | 4 |
Cefepime | Urinary Tract Infections | 26243291;1804010 | 5 |
Atorvastatin | Hypercholesterolemia | 24593216;20946910;20135644 | 6 |
Cefotaxime | Escherichia coli Infections | without evidence | 7 |
Clofibrate | Hypercholesterolemi | 1175893;7080553;7157849 | 8 |
Fenofibrate | Hypercholesterolemi | 2492189;24593216;2045526 | 9 |
Levofloxacin | Escherichia coli Infections | without evidence | 10 |